W. Mark Watson Insider Trading $HPPI Inhibitor Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for W. Mark Watson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of W. Mark Watson. W. Mark Watson is Director in SYKES ENTERPRISES INC ($SYKE) and Director in HedgePath Pharmaceuticals, Inc. ($HPPI) and Director in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI).
W. Mark Watson in Inhibitor Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of W. Mark Watson: Director
Holdings: 310,000 shares
Current Value: $108,500
Latest Transaction: Dec 28 2020
$HPPI Market Capitalization: $100.58M
$HPPI Previous Close: $0.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of W. Mark Watson in Inhibitor Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BDSI, HPPI, SYKE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28 2020 | HPPI | Inhibitor Therapeu ... | Watson W. Mark | Director | Option Exercise | A | 0.03 | 1,306,452 | 40,500 | 1,306,452 | |
| Mar 24 2020 | HPPI | Inhibitor Therapeu ... | Watson W. Mark | Director | Option Exercise | A | 0.05 | 1,500,000 | 75,000 | 1,500,000 | |
| Jun 10 2019 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.07 | 25,000 | 1,825 | 25,000 | |
| Feb 05 2019 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.08 | 657,895 | 50,000 | 657,895 | |
| Mar 15 2018 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.27 | 76,000 | 20,687 | 76,000 | |
| Mar 15 2018 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.27 | 253,000 | 68,867 | 253,000 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | M | 0.00 | 200,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | M | 0.00 | 400,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | M | 0.00 | 300,000 | 0 | 0 | |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Payment of Exercise | F | 0.34 | 79,200 | 26,928 | 553,600 | 632.8 K to 553.6 K (-12.52 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Buy | M | 0.00 | 200,000 | 0 | 632,800 | 432.8 K to 632.8 K (+46.21 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Payment of Exercise | F | 0.34 | 158,400 | 53,856 | 432,800 | 591.2 K to 432.8 K (-26.79 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Buy | M | 0.00 | 400,000 | 0 | 591,200 | 191.2 K to 591.2 K (+209.21 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Payment of Exercise | F | 0.34 | 118,800 | 40,392 | 191,200 | 310 K to 191.2 K (-38.32 %) |
| Mar 10 2017 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Buy | M | 0.00 | 300,000 | 0 | 310,000 | 10 K to 310 K (+3,000.00 %) |
| Jul 06 2016 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.24 | 200,000 | 48,000 | 200,000 | |
| Jul 06 2016 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Aug 18 2015 | HPPI | HedgePath Pharmace ... | Watson W. Mark | Director | Option Exercise | A | 0.00 | 400,000 | 0 | 400,000 |
Page: 1